Carboxylic acid salts
Sigma Aldrich Fine Chemicals Biosciences Glycerol phosphate disodium salt hydrate isomeric mixture | 55073-41-1 | MFCD00149082 | 1KG
Glycerol phosphate disodium salt hydrate isomeric mixture | 55073-41-1 | MFCD00149082 | 1KG
TARGETMOL CHEMICALS INC PSB-12379 DITRIETHYLAMIN 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. PSB-12379 ditriethylamine salt a nucleotide analogue is a potent Ecto-5'-Nucleotidase (CD73) inhibitor with Kis of 9.03 nM (rat) and 2.21 nM (human).
Apexbio Technology LLC (S)-Naproxen,25g CAS# 22204-53-1
(S)-Naproxen is a non-selective COX inhibitor [1,2].Cyclooxygenase (COX) is the key enzyme required for the conversion of arachidonic acid to prostaglandins. Cyclooxygenase enzymes have been involved in diverse physiological situations and disease processes ranging from inflammation to cancer. Until now, two cyclooxygenase isoforms have been identified, COX-1 and COX-2. The COX-1 enzyme is produced constitutively (i.e., gastric mucosa) and COX-2 is inducible (i.e., sites of inflammation) [3]. (S)-Naproxen inhibited the activity of human recombinant COX-1 and -2 with the IC50 values of 0.6-4.8 μM and 2.0-28.4 μM, respectively [1]. (S)-naproxen bound tightly to Aβfibrils with the Ki value of 5.70 ± 1.31 nM against [18F]FDDNP [2]. Pretreatment with (S)-naproxen significantly reduced the specific binding of [18F]FDDNP to regions of gray matter with SPs in AD specimens [4]. Other sizes are also available. Please inqury us for quote.
Apexbio Technology LLC Cefonicid (sodium salt) 61270-78-8 1g
Cefonicid sodium salt (CAS 61270-78-8) is a second-generation cephalosporin antibiotic targeting penicillin-binding proteins (PBPs) It is designed to inhibit bacterial cell wall synthesis thereby exerting bactericidal effects against susceptible bacteria Cefonicid sodium salt acts through inhibition of bacterial cell wall synthesis by binding to PBPs In vitro studies indicate potent inhibition of pathogens such as Neisseria gonorrhoeae with minimal inhibitory concentration (MIC) values typically 2 g/mL Based on these pharmacological properties cefonicid sodium salt holds research potential for studying and treating urinary tract infections lower respiratory tract infections soft tissue infections osteomyelitis and uncomplicated gonorrhea
Avanti Polar Lipids CARBOXYLIC ACID 50 MG
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000] (sodium salt) | 1403744-37-5
eMolecules Ambeed / Dibutylstannanediyl bis(2-ethylhexanoate) / 5g / 633659262 / A1150237 / / 2781-10-4 / MFCD00015261 / 519.354 / C24H48O4Sn
Ambeed / Dibutylstannanediyl bis(2-ethylhexanoate) / 5g / 633659262 / A1150237 / / 2781-10-4 / MFCD00015261 / 519.354 / C24H48O4Sn
Cambridge Isotope Laboratories SUCCINIC ACID, DISODIUM SALT (2,3-13C2, 99%), 1 G, 83587-80-8
SUCCINIC ACID, DISODIUM SALT (2,3-13C2, 99%), 1 G, 83587-80-8
eMolecules DL-Lithium lactate | 100G | Ships from Wood Dale, IL | Chem-Impex | 16891-53-5 | MFCD00065399 | MW: 96.01
Chem-Impex | DL-Lithium lactate | 100G | 16891-53-5 | MFCD28397375 | MW:86.84
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
AdipoGen D Galacturonic acid Na
Chemical. CAS 14984-39-5. Formula C6H9NaO7. MW 216.12. Synthetic. A sugar acid sodium salt preparation.
Selleck Chemical LLC Phosphoramidon Disodium Salt
Phosphoramidon Disodium Salt is a metalloendopeptidase inhibitor widely used as a biochemical tool Phosphoramidon inhibited ECE NEP and ACE activities with IC50 values of 3 5 M 0 034 M and 78 M respectively
Apexbio Technology LLC AVE 0991 sodium salt 306288-04-0 10mg
AVE 0991 sodium salt (CAS 306288-04-0) is a synthetic non-peptide agonist of the angiotensin-(1-7) receptor Mas Acting as a functional mimic of angiotensin-(1-7) AVE 0991 competitively binds to endothelial cell membranes with an IC50 of 21 35 nM in bovine aortic endothelial cells In vitro treatment with AVE 0991 promotes nitric oxide release to levels significantly greater than angiotensin-(1-7) In vivo AVE 0991 reduces urine volume and increases urine osmolality in mice effects reversed by angiotensin II antagonists indicating receptor specificity It also inhibits atherogenesis in ApoE knockout mice supporting its application in cardiovascular and renal research